FDA Drugs (New Approvals & NDA)Original article
2026 DIA/FDA Oligonucleotide-Based Therapeutics Conference - 09/23/2026
ConferenceNeutral
AI Analysis
Summary
The FDA and DIA are jointly organizing a 2026 Oligonucleotide-Based Therapeutics Conference scheduled for September 23, 2026, to facilitate dialogue between regulators and industry on developmental, safety, and manufacturing aspects of oligonucleotide therapeutics.
Importance:2/10
Sentiment:
0.00
oligonucleotide therapeuticsregulatoryCMCclinical pharmacologyconference
Read the original article
Published by FDA Drugs (New Approvals & NDA) on September 14, 2026 7:30 PM